Latest Breaking News On - Cantex pharmaceuticals - Page 4 : vimarsana.com

Cantex Pharmaceuticals Announces Initiation of an Investigator-Initiated Phase 2 Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain Metastases

/PRNewswire/ Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other.

United statesDaniel kontoh boatengCasey mcdonaldJuanf rodriguezRupesh kotechaStepheng marcusCantex pharmaceuticals incTv therapeutics incBaptist health south floridaPrnewswire cantex pharmaceuticals incChief executive officerCentral nervous system metastasisMiami cancer instituteBaptist health southCantex pharmaceuticalsHealth care amp hospitals

vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update

vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Selina husain robert flammPaul sekhriLee rothburns mcclellanPh dburns mcclellan incTv therapeutics incTv therapeutics inc condensed consolidated balance sheetsCantex pharmaceuticalsResearch development rd expensesChief executive officerBreakthrough therapy designationMinimum bid requirementRedeemable noncontrolling interestMonths endedjuneAnnual reportLee rothburnsSelina husain

vTv Therapeutics (VTVT) Reports Q2 Results

vTv Therapeutics (VTVT) Reports Q2 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Paul sekhriSelina husain robert flammLee rothburns mcclellanResearch development rd expensesTv therapeutics incPh dburns mcclellan incCantex pharmaceuticalsTv therapeutics inc condensed consolidated balance sheetsChief executive officerBreakthrough therapy designationMinimum bid requirementRedeemable noncontrolling interestMonths endedjuneAnnual reportLee rothburnsSelina husain

vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update

vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Dburns mcclellanPaul sekhriSelina husain robert flammLee rothCantex pharmaceuticalsTv therapeutics incResearch development rd expensesBurns mcclellan incQuarter financial resultsProvides corporateChief executive officerBreakthrough therapy designationMinimum bid requirementRedeemable noncontrolling interestConsolidated statementsAnnual report

Cantex Pharmaceuticals Announces Article Published in npj Breast Cancer Highlighting Potential Role of RAGE Inhibition to Prevent Metastasis in Triple-Negative Breast Cancer

/PRNewswire/ Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other.

Daniel kontoh boatengStepheng marcusBarry hudsonCasey mcdonaldMarc lippmanTv therapeutics incPrnewswire cantex pharmaceuticals incUniversity of miamiGeorgetown lombardi comprehensive cancer centerBreast cancer research foundationCantex pharmaceuticals incGeorgetown universityGeorgetown university lombardi comprehensive cancer centerMiller school of medicineBreast cancerNature portfolio